Clinical Director, Transplant Infectious Disease
Department of Medicine, Infectious Disease Division
Massachusetts General Hospital

Camille Nelson Kotton is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and an associate professor of medicine at Harvard Medical School in Boston, MA. She has worked in the field of transplantation since 2001. She was the president of the TTS Transplant Infectious Disease Section (2007-2014), chair of the American Society of Transplantation Infectious Disease Executive Committee (2014-2016), and served as councilor for TTS (2020-2024), on the TTS Fundraising Committee, and co-chair of the TTS Education Committee since 2022. She has led four versions of the TTS-supported International Consensus Guidelines on CMV Management after Solid Organ Transplant (2008, 2012, 2017, 2024) and co-led the Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation (2024), all published in Transplantation, where she serves as associate editor. She has a special interest in international transplant work and was integrally involved in the TTS-supported guidelines on Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America (2018) and South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors (2023).

Nephrologist, Westmead Hospital Clinician Researcher
Westmead Institute for Medical Research

Jen is a transplant nephrologist working at Westmead Hospital and has an active research portfolio in cell therapies and transplant genomics at the Westmead Institute for Medical Research.

Diretor, Center for Transplant Science
Vanderbilt University, Nashville, TN, USA

Peter Reese, MD, PhD directs Vanderbilt’s Center for Transplant Science. He is a transplant nephrologist. His research aims to improve access to transplant and the care of solid organ transplant recipients with tools from epidemiology, ethics and policy. His scientific work includes co-leading pioneering trials that demonstrated the safety and efficacy of transplanting organs from donors with hepatitis C virus infection into uninfected recipients. For his contributions to transplant science and ethics, he received a Presidential Early Career Award for Scientists and Engineers at the White House and was elected member of the American Society for Clinical Investigation. Dr. Reese is past Chair of the Ethics Committee for the United Network for Organ Sharing (UNOS), which oversees US organ allocation and transplant regulation. His mission encompasses energetic support of talented and motivated young researchers at all stages of training.

Professor of Nephrology and Epidemiology
Necker Hospital, Paris Cité University
Director of Paris Institute for Transplantation and Organ Regeneration (PITOR)
INSERM U970 – PARCC
Paris, France

Alexandre Loupy, MD, PhD, is Professor of Nephrology and Epidemiology at Necker Hospital and Université Paris Cité, where he leads the Paris Institute for Transplantation & Organ Regeneration (PITOR). He coordinates a national transplant network (11 centers, 8000+ patients) and co-chairs the Banff classification. His research focuses on precision diagnostics in allo- and xenotransplantation, including risk prediction and stratification, immune response, and organ rejection. He has pioneered data-driven methods that reshaped transplant medicine and received major national and European grants in transplant science, including ERC Consolidator Grant 2023 for AI-Care.

PhD Student, Paris Institute for Transplantation and Organ Regeneration
Université Paris Cité, INSERM U970 – PARCC
Paris, France

Marta Sablik, MD, is a PhD student at the Paris Institute for Transplantation and Organ Regeneration, supervised by Pr. Alexandre Loupy. She holds medical and research master’s degrees from Erasmus University Rotterdam. In 2023, she was awarded a doctoral contract through a competitive selection process at Université Paris Cité (ED562 BioSPC, INSERM U970). Her research spans kidney and lung transplantation, combining epidemiological and molecular approaches to study microvascular inflammation in kidney allografts and enhance diagnostic classification of lung allograft rejection.